Xiaobin Zeng

2.1k total citations
88 papers, 1.7k citations indexed

About

Xiaobin Zeng is a scholar working on Molecular Biology, Plant Science and Oncology. According to data from OpenAlex, Xiaobin Zeng has authored 88 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 20 papers in Plant Science and 9 papers in Oncology. Recurrent topics in Xiaobin Zeng's work include Natural product bioactivities and synthesis (15 papers), Phytochemistry and Biological Activities (13 papers) and Essential Oils and Antimicrobial Activity (9 papers). Xiaobin Zeng is often cited by papers focused on Natural product bioactivities and synthesis (15 papers), Phytochemistry and Biological Activities (13 papers) and Essential Oils and Antimicrobial Activity (9 papers). Xiaobin Zeng collaborates with scholars based in China, United States and Lebanon. Xiaobin Zeng's co-authors include Jun Tian, Haoqiang Wan, Lanlan Ge, Xue Peng, Xiangjiu He, Boping Zhou, Jiemei Li, Weigang Wu, Nianhong Chen and Guoqing Wan and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Xiaobin Zeng

84 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobin Zeng China 25 747 363 277 230 159 88 1.7k
Dorina Coricovac Romania 25 743 1.0× 278 0.8× 240 0.9× 230 1.0× 174 1.1× 72 2.0k
Somi K. Cho South Korea 19 697 0.9× 436 1.2× 274 1.0× 140 0.6× 138 0.9× 41 1.6k
Marius Mioc Romania 21 673 0.9× 244 0.7× 238 0.9× 151 0.7× 139 0.9× 67 1.6k
Iulia Pînzaru Romania 21 572 0.8× 229 0.6× 182 0.7× 187 0.8× 181 1.1× 83 1.5k
Allen Y. Chen United States 13 952 1.3× 326 0.9× 137 0.5× 307 1.3× 282 1.8× 16 2.0k
Katarína Kozics Slovakia 20 442 0.6× 340 0.9× 408 1.5× 108 0.5× 142 0.9× 44 1.3k
Martin Kello Slovakia 26 779 1.0× 298 0.8× 122 0.4× 127 0.6× 200 1.3× 82 1.9k
Zhenliang Sun China 25 759 1.0× 334 0.9× 280 1.0× 104 0.5× 98 0.6× 92 1.9k
Jaehwi Lee South Korea 22 804 1.1× 276 0.8× 212 0.8× 120 0.5× 146 0.9× 38 2.2k
Ștefana Avram Romania 21 515 0.7× 260 0.7× 246 0.9× 95 0.4× 156 1.0× 62 1.3k

Countries citing papers authored by Xiaobin Zeng

Since Specialization
Citations

This map shows the geographic impact of Xiaobin Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Zeng more than expected).

Fields of papers citing papers by Xiaobin Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobin Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Zeng. The network helps show where Xiaobin Zeng may publish in the future.

Co-authorship network of co-authors of Xiaobin Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobin Zeng. A scholar is included among the top collaborators of Xiaobin Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobin Zeng. Xiaobin Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yang, Meiying Wu, Haoqiang Wan, et al.. (2025). Enhancing GSDME-induced pyroptosis through low-dose doxorubicin/biflavonoid derivative co-loaded nanodisc in hepatocellular carcinoma. Drug Delivery. 32(1). 2587034–2587034.
2.
Ye, Junyi, Xiaobin Zeng, Ao Lin, et al.. (2024). Robust positive association between serum urate and the risk of chronic obstructive pulmonary disease: hospital-based cohort and Mendelian randomisation study. BMJ Open Respiratory Research. 11(1). e002203–e002203. 5 indexed citations
3.
Wang, Yunchao, Ao Lin, Xiaobin Zeng, et al.. (2023). The role of EPAS1 polymorphisms on COPD susceptibility in southern Chinese. Heliyon. 9(10). e20226–e20226. 1 indexed citations
4.
5.
Wan, Haoqiang, Yi Cai, Lingyun Xiao, et al.. (2023). JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. Oxidative Medicine and Cellular Longevity. 2023. 1–21. 3 indexed citations
6.
Wei, Xiaofang, et al.. (2023). A Novel Caffeoylquinic Acid from Lonicera japonica Exerts Cytotoxic Activity by Blocking the YAP-CTGF Signaling Pathway in Hepatocellular Carcinoma. Revista Brasileira de Farmacognosia. 33(4). 736–746. 3 indexed citations
7.
Li, Shiyang, et al.. (2023). Association between serum albumin to serum creatinine ratio and mortality risk in patients with heart failure. Clinical and Translational Science. 16(11). 2345–2355. 9 indexed citations
8.
Wang, Yunchao, Xiaoyi Zhang, Ao Lin, et al.. (2023). EPO rs1617640 A>C is a Protective Factor for Chronic Obstructive Pulmonary Disease: A Case Control Study. Frontiers in Bioscience-Landmark. 28(9). 215–215. 1 indexed citations
9.
Yin, Zhao, Xiuyuan Wang, Rui Su, et al.. (2023). System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells. Phytomedicine. 117. 154918–154918. 5 indexed citations
10.
Chen, Pengfei, Guoqing Huang, Huimin Sun, et al.. (2022). Salt-inducible kinases inhibitor HG-9-91-01 targets RIPK3 kinase activity to alleviate necroptosis-mediated inflammatory injury. Cell Death and Disease. 13(2). 188–188. 24 indexed citations
11.
Chen, Nianhong, Qiaoqiao Zheng, Guoqing Wan, et al.. (2021). Impact of posttranslational modifications in pancreatic carcinogenesis and treatments. Cancer and Metastasis Reviews. 40(3). 739–759. 9 indexed citations
12.
Cheng, Tao, et al.. (2020). Total synthesis of tubulysin U and N14-desacetoxytubulysin H. Organic & Biomolecular Chemistry. 18(28). 5349–5353. 7 indexed citations
13.
Fu, Chaoying, Vladimír Vrkoslav, Silvia Orlandi, et al.. (2020). Surface-Confined Macrocyclization via Dynamic Covalent Chemistry. ACS Nano. 14(3). 2956–2965. 9 indexed citations
14.
15.
Zeng, Xiaobin, Chengxiao Liu, Jie Yao, et al.. (2020). Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications. Pharmacological Research. 163. 105320–105320. 114 indexed citations
16.
Wang, Yang, Ji Chen, Keda Zhang, et al.. (2018). Chemical Composition, Proapoptotic and Antiosteoporosis Activities of the Essential Oil from the Aerial Part of <i>Alpinia officinarum</i> Hance. Chinese Medicine. 9(3). 144–164. 1 indexed citations
17.
Zeng, Xiaobin, et al.. (2018). Compression neuropathy of common peroneal nerve caused by a popliteal cyst. Medicine. 97(16). e9922–e9922. 5 indexed citations
18.
Zeng, Xiaobin, et al.. (2016). Two new dammarane triterpenes from the leaves of Ceriops tagal.. Records of Natural Products. 10(5). 628–632. 5 indexed citations
19.
Zeng, Xiaobin, Limin Xiang, Chenyang Li, et al.. (2012). Cytotoxic ceramides and glycerides from the roots of Livistona chinensis. Fitoterapia. 83(3). 609–616. 21 indexed citations
20.
He, Xiangjiu, Hui Hu, Yixuan Wu, & Xiaobin Zeng. (2011). Urinary metabolites of cinobufagin in rats and their antiproliferative activities. Natural Product Research. 26(6). 489–499. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorina Coricovac Breakdown of academic impact, for papers by Somi K. Cho Breakdown of academic impact, for papers by Marius Mioc Breakdown of academic impact, for papers by Iulia Pînzaru Breakdown of academic impact, for papers by Allen Y. Chen Breakdown of academic impact, for papers by Katarína Kozics Breakdown of academic impact, for papers by Martin Kello Breakdown of academic impact, for papers by Zhenliang Sun Breakdown of academic impact, for papers by Jaehwi Lee Breakdown of academic impact, for papers by Ștefana Avram
Rankless by CCL
2026